MeiraGTx trades flat after $75M IPO

Gene therapy play MeiraGTx Holdings plc (NASDAQ:MGTX) shares were unchanged June 8 after the company raised $75 million via the sale of 5 million shares at $15 in an IPO underwritten by BofA Merrill Lynch, Barclays, Evercore ISI and Chardan.

MeiraGTx anticipated selling 5 million shares and priced at the midpoint of its proposed range of $14-$16. The price valued MeiraGTx at $407.8 million...